Other Events ·
BioRestorative Therapies, Inc. received a delinquency notification from Nasdaq on August 21, 2026, for failing to…
BRTXBioRestorative Therapies, Inc.
BioRestorative Therapies, Inc. received a delinquency notification from Nasdaq on August 21, 2026, for failing to timely file its Form 10-Q for the quarter ended June 30, 2026, violating Listing Rule 5250(c)(1). The company has until October 20, 2026, to submit a compliance plan and may receive an extension until February 16, 2027. Failure to regain compliance could result in delisting from the Nasdaq Capital Market under symbol BRTX. BioRestorative Therapies, Inc. operates in the biotechnology industry, developing cell-based therapies for regenerative medicine.